About Semalytix
Semalytix is a Healthcare company based in Bielefeld (Germany) founded in 2015. AI-based data analytics solutions are offered for researchers and industries. It operates in the Healthcare and Technology sectors. Semalytix has raised $14.17 million across 5 funding rounds from investors including NRW.Bank, European Union and The Hundert. The company has 67 employees. Semalytix offers products and services including PatientGPT, Pharos Suite, Patient Journeys, PatientX Datastream, and AI-Powered Reports. Its focus areas include Enterprise Applications, Vertical Business Intelligence, Industry Specific and HealthTech. Its legal entity is Semalytix GmbH.
Company details
Semalytix was established in 2015 in Bielefeld, Germany, focusing on artificial intelligence and machine learning applications. Analytics solutions are provided for sectors including marketing, business intelligence, financial services, and pharmaceuticals. Tools like Pharos are developed to support decision-making using patients health records, population statistics, and related datasets, serving global research and business needs.
- Headquarters Bielefeld, Germany
- Employees 67
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website semalytix.com
- Social LinkedIn X
- Legal Name Semalytix Gmbh
- Total Equity Funding$14.17M (USD)
in 5 rounds
- Latest Funding Round$6.64M (USD), Series B
Oct 2025
- InvestorsNRW.Bank
& 5 more
- Employee Count67
Products & Services of Semalytix
Semalytix offers a comprehensive portfolio of products and services, including PatientGPT, Pharos Suite, Patient Journeys, PatientX Datastream, and AI-Powered Reports.
AI tool for generating insights from patient experience data points.
Platform that processes patient conversations for research acceleration.
Tool for mapping authentic patient experiences across languages.
Service providing real-time patient experience data for pharma.
Software for summarizing medical texts and patient insights.
Funding Insights of Semalytix
Semalytix has successfully raised a total of $14.17M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6.64 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.17M
- Total Rounds 5
- Last Round Series B — $6.64M
- Investors Count 6
All 5 funding rounds of Semalytix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $6.64M | Series B | – | Holland Capital | – |
| Feb 2021 | $2.41M | Series A | – | NRW.Bank | – |
| Aug 2020 | $5.12M | Series A | – | b2venture | |
| Jan 2019 | $392,981 | Grant | – | – | |
| Nov 2018 | Seed | – | The Hundert | – |
6 investors in total: 6 institutional.
Investors in Semalytix
Semalytix has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include NRW.Bank, European Union and The Hundert.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in European tech startups from day-zero to seed. | fly.vc | |||
Venture capital is provided to innovative startups by b2venture. | b2venture.vc | St. Gallen, Switzerland | ||
Holland Capital is engaged in venture and growth investments. | hollandcapital.nl | |||
Loans, advice, seminars, and networks are provided for financial support. | 2001 | nrwbank.de | Dusseldorf, Germany | |
| the-hundert.com | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Semalytix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Semalytix
3 dated milestones of Semalytix across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Semalytix is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $6.6M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Semalytix
Complete news archive for Semalytix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Semalytix
Semalytix was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Semalytix is headquartered in Bielefeld, Germany. It is registered at Bielefeld, North Rhine-westphalia, Germany.
Semalytix is a funded company, having raised a total of $14.17M across 5 funding rounds to date.
Semalytix has 67 employees.
Semalytix was established in 2015 in Bielefeld, Germany, focusing on artificial intelligence and machine learning applications. Analytics solutions are provided for sectors including marketing, business intelligence, financial services, and pharmaceuticals. Tools like Pharos are developed to support decision-making using patients health records, population statistics, and related datasets, serving global research and business needs.
Semalytix offers PatientGPT, Pharos Suite, Patient Journeys, PatientX Datastream, and AI-Powered Reports.
Semalytix has 6 investors. Key investors include NRW.Bank, European Union, The Hundert, Fly Ventures, and b2venture.
Semalytix operates through Semalytix Gmbh.